Ticker: STOK

Company: Stoke Therapeutics, Inc.

Person: Kaye Edward M MD, director

Transaction date: Dec. 1, 2025

Reporting date: Dec. 3, 2025

Average share price: -29.592584227418616

Sold 2181.0 shares for 64541.43